| # | Drug | Count |
|---|---|---|
| 0 | CEMIPLIMAB-RWLC | 2 |
| 1 | DURVALUMAB | 2 |
| 2 | METFORMIN HYDROCHLORIDE | 2 |
| 3 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 2 |
| 4 | METFORMIN HYDROCHLORIDE TABLET | 2 |
| 5 | METFORMIN HYDROCHLORIDE TABLETS | 2 |
| 6 | OMEPRAZOLE | 2 |
| 7 | OMEPRAZOLE MAGNESIUM | 2 |
| 8 | ACETAMINOPHEN | 1 |
| 9 | ACETAMINOPHEN 500MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEMIPLIMAB-RWLC | 2 | 0.0010 |
| 1 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 2 | DURVALUMAB | 2 | 0.0001 |
| 3 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 4 | METFORMIN HYDROCHLORIDE TABLETS | 2 | 0.0000 |
| 5 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 2 | 0.0000 |
| 6 | METFORMIN HYDROCHLORIDE TABLET | 2 | 0.0000 |
| 7 | METFORMIN HYDROCHLORIDE | 2 | 0.0000 |
| 8 | CYANOCOBALAMIN | 1 | 0.0000 |
| 9 | IPILIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |